Literature DB >> 21524971

Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome.

Hung-Wei Chi1, Ya-Sung Yang, Shi-Ta Shang, Ke-Hung Chen, Kuo-Ming Yeh, Feng-Yee Chang, Jung-Chung Lin.   

Abstract

BACKGROUND: Candidemia caused by non-albicans Candida spp. is of special concern because of its high drug resistance and increase in prevalence. In clinical practice, early identification of non-albicans candidemia is crucial. We investigated the outcome in patients with candidemia caused by Candida albicans and Candida non-albicans.
METHODS: We retrospectively evaluated candidemic patients from October 2007 to July 2009. Underlying diseases, predisposing factors, laboratory data, and outcome were analyzed.
RESULTS: One hundred and eight patients of candidemia were enrolled. Candida albicans and non-albicans spp. were responsible for 56.5% (61 of 108) and 43.5% (47 of 108) of candidemia cases, respectively. Among patients with non-albicans candidemia, significantly more patients had neutropenia (p=0.001) and less patients had candiduria (p=0.001) and intensive care unit stay (p=0.002) in comparison with those with C albicans candidemia. All-cause Day 7 mortality was high in both C albicans and non-albicans spp. candidemia [44.3% (27 of 61) vs. 29.8% (14 of 47)]. Multivariate analysis revealed that poor renal function (odds ratio, 1.035; 95% confidence interval, 1.001-1.071; p=0.04) and shock (odds ratio, 19.4; 95% confidence interval, 2.53-149.5; p=0.004) are independent risk factors for fatal candidemia.
CONCLUSIONS: The outcome of candidemia was poor. The identified risk factors may help us to differentiate fatal candidemia in early infection.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21524971     DOI: 10.1016/j.jmii.2010.08.010

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  29 in total

1.  Accurate and rapid identification of Candida spp. frequently associated with fungemia by using PCR and the microarray-based Prove-it Sepsis assay.

Authors:  Anne Aittakorpi; Pentti Kuusela; Pirkko Koukila-Kähkölä; Martti Vaara; Michael Petrou; Vanya Gant; Minna Mäki
Journal:  J Clin Microbiol       Date:  2012-09-05       Impact factor: 5.948

2.  Factors Influencing Non-albicans Candidemia: A Case-Case-Control Study.

Authors:  Diamantis P Kofteridis; Antonis Valachis; Dimitra Dimopoulou; Angeliki M Andrianaki; Athanasia Christidou; Sofia Maraki; Nikolaos A Spernovasilis; George Samonis
Journal:  Mycopathologia       Date:  2017-05-19       Impact factor: 2.574

Review 3.  Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment.

Authors:  Natália Martins; Isabel C F R Ferreira; Lillian Barros; Sónia Silva; Mariana Henriques
Journal:  Mycopathologia       Date:  2014-05-01       Impact factor: 2.574

4.  Synergistic effect of the flavonoid catechin, quercetin, or epigallocatechin gallate with fluconazole induces apoptosis in Candida tropicalis resistant to fluconazole.

Authors:  Cecília Rocha da Silva; João Batista de Andrade Neto; Rosana de Sousa Campos; Narjara Silvestre Figueiredo; Letícia Serpa Sampaio; Hemerson Iury Ferreira Magalhães; Bruno Coêlho Cavalcanti; Danielle Macêdo Gaspar; Geanne Matos de Andrade; Iri Sandro Pampolha Lima; Glauce Socorro de Barros Viana; Manoel Odorico de Moraes; Marina Duarte Pinto Lobo; Thalles Barbosa Grangeiro; Hélio Vitoriano Nobre Júnior
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

5.  Synergistic effects of amiodarone and fluconazole on Candida tropicalis resistant to fluconazole.

Authors:  Cecília Rocha da Silva; João Batista de Andrade Neto; José Júlio Costa Sidrim; Maria Rozzelê Ferreira Angelo; Hemerson Iury Ferreira Magalhães; Bruno Coêlho Cavalcanti; Raimunda Sâmia Nogueira Brilhante; Danielle Silveira Macedo; Manoel Odorico de Moraes; Marina Duarte Pinto Lobo; Thalles Barbosa Grangeiro; Hélio Vitoriano Nobre Júnior
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

6.  Ten-year review of candidemia in a Canadian tertiary care centre: Predominance of non-albicans Candida species.

Authors:  Ghada N Al-Rawahi; Diane L Roscoe
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

7.  Enterogenous infection of Candida albicans in immunocompromised rats under severe acute pancreatitis.

Authors:  Xiang-Wang Zhao; Lei Yan; Dan Xu; Yu-Hui Cui; Chun-Hui Yang; Yan-Jun Zhou; Jian-Guo Tang
Journal:  World J Emerg Med       Date:  2016

8.  A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.

Authors:  Matteo Bassetti; Monia Marchetti; Arunaloke Chakrabarti; Sergio Colizza; Jose Garnacho-Montero; Daniel H Kett; Patricia Munoz; Francesco Cristini; Anastasia Andoniadou; Pierluigi Viale; Giorgio Della Rocca; Emmanuel Roilides; Gabriele Sganga; Thomas J Walsh; Carlo Tascini; Mario Tumbarello; Francesco Menichetti; Elda Righi; Christian Eckmann; Claudio Viscoli; Andrew F Shorr; Olivier Leroy; George Petrikos; Francesco Giuseppe De Rosa
Journal:  Intensive Care Med       Date:  2013-10-09       Impact factor: 17.440

9.  High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan.

Authors:  Jih-Luh Tang; Hsiang-Chi Kung; Weng-Chi Lei; Ming Yao; Un-In Wu; Szu-Chun Hsu; Chien-Ting Lin; Chi-Cheng Li; Shang-Ju Wu; Hsin-An Hou; Wen-Chien Chou; Shang-Yi Huang; Woei Tsay; Yao-Chang Chen; Yee-Chun Chen; Shan-Chwen Chang; Bor-Sheng Ko; Hwei-Fang Tien
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

10.  Synthesis, structure optimization and antifungal screening of novel tetrazole ring bearing acyl-hydrazones.

Authors:  Maqsood Ahmad Malik; Shaeel Ahmed Al-Thabaiti; Manzoor A Malik
Journal:  Int J Mol Sci       Date:  2012-08-30       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.